Evaluation of wound healing and chemotactic activities of Embelin and Vilangin using human dermal fibroblast (in vitro) model
ABSTRACT:
Plants or plant based products have been used in the
traditional healthcare system from time immemorial for treatment of various
diseases; wound healing is one among them. The aim of present study is to
understand the 2, 5- dihydroxy-3-undecyl-1, 4-benzoquinone (Embelin) and
dimeric form of embelin (Vilangin) mediated attenuation of wound healing and
cell migration at the cellular level. We used fibroblast cell based model for
studying cytotoxicity, wound healing and Boyden’s chamber migration assay. In
addition to this, effect of cell migration of both embelin and vilangin was
studied at the single cell level using live cell imaging technique. Results,
shown that the concentration required for 50% cyotoxicity (IC50) towards human
dermal fibroblast cells was determined as 32 ± 1 µg/ml & 15 ± 2 µg/ml for
embelin and vilangin respectively. Furthermore 0.1 and 1.0 µg/ml concentration
were chosen for further wound healing and migration studies. Results
demonstrate that both embelin and vilangin arrests wound healing (at 0.1, 1.0
µg/ml concentration level individually) and moreover human dermal fibroblast
(HDF) migration was significantly reduced after treatment with both embelin and
vilangin respectively. Our present findings demonstrated both embelin and
dimeric form of embelin (vilangin) inhibits wound healing and cell migration.
Therefore both could be used as potential drug candidates for anti-angiogenesis
therapy.
Further details to
visit: http://www.jocpr.com/
For more details
visit: http://www.jocpr.com/articles/evaluation-of-wound-healing-and-chemotactic-activities-of-embelin-and-vilangin-using-human-dermal-fibroblast-in-vitro-mo.pdf
Comments
Post a Comment